Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine—leading ...
Apr 3, 2024
0
42
People who can't visualize an image in their mind's eye are less likely to remember the details of important past personal events or to recognize faces, according to a review of nearly 10 years of research.
Mar 27, 2024
2
136
Scientists from The Australian National University (ANU) have discovered a gene mutation is responsible for causing psoriasis—a chronic inflammatory skin disease that causes patients to develop red, scaly and itchy patches ...
Mar 25, 2024
0
117
New research from Oregon Health & Science University describes the science behind a promising technique to treat infertility by turning a skin cell into an egg that is capable of producing viable embryos.
Mar 8, 2024
0
73
Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses. Published in IEEE Transactions ...
Feb 20, 2024
0
46
Academic researchers from King's College London have investigated the early effects of an immunosuppressant drug that could help clinicians with future personalized approaches for the treatment of psoriasis.
Feb 19, 2024
0
19
When diagnosing skin diseases based solely on images of a patient's skin, doctors do not perform as well when the patient has darker skin, according to a new study from MIT researchers.
Feb 5, 2024
0
35
A team of medical researchers and chemical engineers at National Tsing Hua University, working with a colleague from Taipei Medical University, has developed a skin patch that can monitor the size of a tumor lying just under ...
Biomedical engineers at Duke University have demonstrated that one of the most dangerous mutations found in skin cancers might moonlight as a pathway to mending a broken heart.
Jan 24, 2024
0
55
A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the inhibition of a specific signaling pathway ...
Jan 23, 2024
0
27
